Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anterior Cruciate Ligament | 87 | 2024 | 423 | 15.160 |
Why?
|
Wound Healing | 49 | 2024 | 2805 | 4.770 |
Why?
|
Tissue Scaffolds | 30 | 2019 | 934 | 4.490 |
Why?
|
Knee Injuries | 20 | 2024 | 488 | 4.230 |
Why?
|
Platelet-Rich Plasma | 18 | 2024 | 178 | 3.920 |
Why?
|
Collagen | 35 | 2022 | 2638 | 3.880 |
Why?
|
Knee Joint | 29 | 2023 | 1676 | 3.410 |
Why?
|
Cartilage, Articular | 14 | 2023 | 1099 | 2.760 |
Why?
|
Osteoarthritis | 9 | 2023 | 1063 | 2.650 |
Why?
|
Fibroblasts | 23 | 2013 | 4141 | 2.330 |
Why?
|
Swine | 50 | 2023 | 5915 | 2.320 |
Why?
|
Synovial Membrane | 9 | 2023 | 532 | 2.240 |
Why?
|
Swine, Miniature | 26 | 2023 | 961 | 1.940 |
Why?
|
Blood Platelets | 15 | 2015 | 2479 | 1.840 |
Why?
|
Sterilization | 4 | 2021 | 133 | 1.830 |
Why?
|
Extracellular Matrix | 11 | 2022 | 1726 | 1.550 |
Why?
|
Tissue Engineering | 13 | 2015 | 1868 | 1.380 |
Why?
|
Synovitis | 2 | 2023 | 217 | 1.270 |
Why?
|
Hydrogels | 6 | 2022 | 720 | 1.270 |
Why?
|
Device Approval | 2 | 2022 | 163 | 1.140 |
Why?
|
Collagen Type I | 6 | 2015 | 616 | 1.070 |
Why?
|
Suture Techniques | 5 | 2015 | 769 | 1.000 |
Why?
|
Collagen Type III | 5 | 2013 | 91 | 0.980 |
Why?
|
Platelet Transfusion | 4 | 2012 | 297 | 0.930 |
Why?
|
Tibia | 11 | 2022 | 1070 | 0.900 |
Why?
|
Osteoarthritis, Knee | 6 | 2024 | 1234 | 0.860 |
Why?
|
Weight-Bearing | 8 | 2015 | 532 | 0.850 |
Why?
|
Models, Animal | 13 | 2015 | 2112 | 0.830 |
Why?
|
Animals | 84 | 2023 | 168459 | 0.810 |
Why?
|
Leukocytes, Mononuclear | 3 | 2012 | 1844 | 0.730 |
Why?
|
Nitrogen | 1 | 2021 | 348 | 0.690 |
Why?
|
Cattle | 11 | 2021 | 3849 | 0.690 |
Why?
|
Platelet Activation | 4 | 2011 | 645 | 0.650 |
Why?
|
Sutures | 4 | 2015 | 284 | 0.640 |
Why?
|
Chondrogenesis | 1 | 2020 | 239 | 0.610 |
Why?
|
Orthopedic Procedures | 7 | 2013 | 1265 | 0.610 |
Why?
|
Joint Instability | 7 | 2012 | 801 | 0.610 |
Why?
|
Sus scrofa | 7 | 2015 | 428 | 0.590 |
Why?
|
Thrombin | 3 | 2011 | 591 | 0.590 |
Why?
|
Femur | 7 | 2021 | 1307 | 0.570 |
Why?
|
Stifle | 4 | 2012 | 28 | 0.560 |
Why?
|
Cell Movement | 7 | 2012 | 5203 | 0.530 |
Why?
|
Triamcinolone Acetonide | 1 | 2016 | 100 | 0.510 |
Why?
|
Mesenchymal Stem Cells | 4 | 2014 | 1642 | 0.510 |
Why?
|
Ethylene Oxide | 1 | 2015 | 28 | 0.510 |
Why?
|
Menisci, Tibial | 5 | 2024 | 267 | 0.500 |
Why?
|
Hindlimb | 5 | 2019 | 513 | 0.470 |
Why?
|
Guided Tissue Regeneration | 2 | 2013 | 88 | 0.460 |
Why?
|
Decorin | 1 | 2014 | 38 | 0.460 |
Why?
|
Tenascin | 1 | 2014 | 62 | 0.450 |
Why?
|
Rotator Cuff | 2 | 2015 | 348 | 0.440 |
Why?
|
Regeneration | 5 | 2015 | 1511 | 0.430 |
Why?
|
Injections, Intra-Articular | 4 | 2022 | 280 | 0.430 |
Why?
|
Magnetic Resonance Imaging | 24 | 2024 | 36426 | 0.430 |
Why?
|
Ligaments | 2 | 2014 | 127 | 0.430 |
Why?
|
Bone Development | 3 | 2011 | 472 | 0.430 |
Why?
|
Biological Products | 1 | 2022 | 914 | 0.420 |
Why?
|
Polyglactin 910 | 1 | 2012 | 55 | 0.420 |
Why?
|
Platelet-Derived Growth Factor | 4 | 2011 | 618 | 0.410 |
Why?
|
Polyethylene Terephthalates | 1 | 2012 | 113 | 0.410 |
Why?
|
Fibrillar Collagens | 1 | 2012 | 42 | 0.410 |
Why?
|
Random Allocation | 6 | 2015 | 2395 | 0.400 |
Why?
|
Plasma | 1 | 2015 | 586 | 0.400 |
Why?
|
Transforming Growth Factor beta1 | 5 | 2011 | 629 | 0.390 |
Why?
|
alpha-Galactosidase | 1 | 2011 | 57 | 0.380 |
Why?
|
Proteome | 2 | 2019 | 1862 | 0.380 |
Why?
|
Growth Plate | 1 | 2012 | 274 | 0.370 |
Why?
|
Cells, Cultured | 16 | 2013 | 18965 | 0.370 |
Why?
|
Bone Transplantation | 3 | 2011 | 929 | 0.370 |
Why?
|
Chondrocytes | 4 | 2021 | 795 | 0.350 |
Why?
|
Erythrocytes | 2 | 2011 | 2413 | 0.350 |
Why?
|
Medial Collateral Ligament, Knee | 2 | 2007 | 23 | 0.350 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2010 | 178 | 0.350 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2010 | 191 | 0.340 |
Why?
|
Extracellular Matrix Proteins | 2 | 2013 | 829 | 0.340 |
Why?
|
Cell Count | 3 | 2021 | 1835 | 0.330 |
Why?
|
Sheep | 5 | 2015 | 1440 | 0.330 |
Why?
|
Surface-Active Agents | 1 | 2009 | 150 | 0.330 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2010 | 302 | 0.320 |
Why?
|
Equipment Failure Analysis | 1 | 2011 | 847 | 0.320 |
Why?
|
Tissue Adhesives | 1 | 2010 | 173 | 0.310 |
Why?
|
Rupture | 6 | 2014 | 443 | 0.310 |
Why?
|
Knee Prosthesis | 1 | 2011 | 395 | 0.310 |
Why?
|
Athletic Injuries | 3 | 2019 | 1216 | 0.310 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 546 | 0.300 |
Why?
|
Gene Expression Profiling | 4 | 2023 | 9420 | 0.300 |
Why?
|
Tendon Injuries | 1 | 2011 | 328 | 0.290 |
Why?
|
Actins | 8 | 2004 | 2050 | 0.290 |
Why?
|
Transforming Growth Factor beta | 4 | 2004 | 1961 | 0.290 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 558 | 0.290 |
Why?
|
Disease Models, Animal | 13 | 2019 | 18252 | 0.280 |
Why?
|
Fibrin | 1 | 2010 | 507 | 0.280 |
Why?
|
Cell Culture Techniques | 3 | 2010 | 1667 | 0.280 |
Why?
|
Tensile Strength | 3 | 2013 | 330 | 0.280 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2010 | 664 | 0.280 |
Why?
|
Connective Tissue | 1 | 2009 | 419 | 0.280 |
Why?
|
Glucocorticoids | 1 | 2016 | 2161 | 0.270 |
Why?
|
Postoperative Complications | 5 | 2017 | 15631 | 0.270 |
Why?
|
Gene Expression Regulation | 4 | 2013 | 11903 | 0.270 |
Why?
|
Matrix Metalloproteinase 1 | 3 | 2017 | 145 | 0.250 |
Why?
|
Dogs | 5 | 2011 | 3839 | 0.250 |
Why?
|
Muscle Strength | 2 | 2020 | 624 | 0.250 |
Why?
|
Transgenes | 2 | 2010 | 1010 | 0.250 |
Why?
|
Cell Proliferation | 9 | 2012 | 10445 | 0.250 |
Why?
|
Tendons | 2 | 2009 | 558 | 0.250 |
Why?
|
Orthopedics | 2 | 2024 | 898 | 0.240 |
Why?
|
Biocompatible Materials | 2 | 2011 | 1685 | 0.240 |
Why?
|
Blood Proteins | 1 | 2010 | 1173 | 0.240 |
Why?
|
Transplantation, Homologous | 3 | 2013 | 4806 | 0.240 |
Why?
|
Synovial Fluid | 3 | 2022 | 393 | 0.240 |
Why?
|
Cytokines | 2 | 2011 | 7396 | 0.240 |
Why?
|
Age Factors | 8 | 2012 | 18395 | 0.230 |
Why?
|
Fractures, Cartilage | 1 | 2004 | 22 | 0.230 |
Why?
|
Cryopreservation | 1 | 2009 | 728 | 0.230 |
Why?
|
Polyethylene Glycols | 1 | 2009 | 1189 | 0.230 |
Why?
|
Rats, Inbred Lew | 3 | 2021 | 1157 | 0.220 |
Why?
|
Matrix Metalloproteinase 13 | 2 | 2014 | 102 | 0.220 |
Why?
|
Patellar Ligament | 2 | 2015 | 64 | 0.220 |
Why?
|
Female | 50 | 2024 | 392644 | 0.220 |
Why?
|
Linear Models | 6 | 2019 | 5871 | 0.220 |
Why?
|
Hemostatics | 1 | 2006 | 241 | 0.210 |
Why?
|
Macrophages | 2 | 2015 | 5769 | 0.210 |
Why?
|
Goats | 3 | 2011 | 165 | 0.210 |
Why?
|
Casts, Surgical | 1 | 2024 | 183 | 0.210 |
Why?
|
Transduction, Genetic | 2 | 2010 | 903 | 0.210 |
Why?
|
Temperature | 1 | 2009 | 2226 | 0.200 |
Why?
|
Male | 45 | 2024 | 360804 | 0.200 |
Why?
|
RNA, Messenger | 4 | 2014 | 12795 | 0.200 |
Why?
|
Humans | 64 | 2024 | 761504 | 0.190 |
Why?
|
Powders | 1 | 2021 | 80 | 0.190 |
Why?
|
Sports Medicine | 1 | 2024 | 240 | 0.190 |
Why?
|
Guinea Pigs | 1 | 2022 | 1310 | 0.180 |
Why?
|
Glycosaminoglycans | 2 | 2001 | 607 | 0.180 |
Why?
|
Aging | 5 | 2011 | 8708 | 0.180 |
Why?
|
Materials Testing | 3 | 2012 | 863 | 0.180 |
Why?
|
Adipose Tissue | 1 | 2012 | 3312 | 0.180 |
Why?
|
Transplantation, Autologous | 3 | 2021 | 2115 | 0.180 |
Why?
|
Gamma Rays | 1 | 2021 | 318 | 0.180 |
Why?
|
Rats | 6 | 2021 | 23742 | 0.170 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2007 | 1934 | 0.170 |
Why?
|
Technology | 1 | 2022 | 292 | 0.170 |
Why?
|
Equipment and Supplies | 1 | 2022 | 273 | 0.170 |
Why?
|
Adolescent | 17 | 2024 | 88319 | 0.160 |
Why?
|
Models, Biological | 3 | 2017 | 9469 | 0.160 |
Why?
|
Gene Expression | 5 | 2012 | 7581 | 0.160 |
Why?
|
Coculture Techniques | 2 | 2012 | 1341 | 0.150 |
Why?
|
Radius Fractures | 1 | 2024 | 515 | 0.150 |
Why?
|
Treatment Outcome | 10 | 2020 | 64680 | 0.150 |
Why?
|
Rheology | 2 | 2009 | 347 | 0.150 |
Why?
|
Cell Survival | 4 | 2021 | 5791 | 0.150 |
Why?
|
Analysis of Variance | 5 | 2013 | 6228 | 0.150 |
Why?
|
Gels | 2 | 2010 | 420 | 0.150 |
Why?
|
Time Factors | 8 | 2016 | 39967 | 0.150 |
Why?
|
Musculoskeletal Diseases | 1 | 2023 | 598 | 0.150 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2022 | 452 | 0.150 |
Why?
|
Quadriceps Muscle | 1 | 2019 | 156 | 0.150 |
Why?
|
Collagen Type II | 2 | 2017 | 148 | 0.140 |
Why?
|
Cell Division | 3 | 2011 | 4465 | 0.140 |
Why?
|
Species Specificity | 2 | 2011 | 2414 | 0.130 |
Why?
|
DNA Fragmentation | 2 | 2006 | 237 | 0.120 |
Why?
|
Immunohistochemistry | 8 | 2010 | 11076 | 0.120 |
Why?
|
Radiography | 4 | 2019 | 6965 | 0.120 |
Why?
|
Culture Media | 2 | 2010 | 897 | 0.120 |
Why?
|
Talus | 2 | 2006 | 86 | 0.120 |
Why?
|
Pattern Recognition, Automated | 1 | 2020 | 997 | 0.120 |
Why?
|
Elastic Modulus | 1 | 2015 | 211 | 0.120 |
Why?
|
Adenoviridae | 3 | 2010 | 1084 | 0.120 |
Why?
|
In Situ Nick-End Labeling | 2 | 2006 | 613 | 0.110 |
Why?
|
Procollagen N-Endopeptidase | 1 | 2013 | 19 | 0.110 |
Why?
|
Blood | 2 | 2015 | 596 | 0.110 |
Why?
|
Electrons | 1 | 2015 | 265 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2022 | 9000 | 0.110 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1664 | 0.110 |
Why?
|
Aggrecans | 1 | 2013 | 89 | 0.110 |
Why?
|
Posterior Cruciate Ligament | 1 | 2014 | 85 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4575 | 0.110 |
Why?
|
Fracture Fixation | 2 | 2024 | 366 | 0.110 |
Why?
|
Radiation Dosage | 1 | 2021 | 1958 | 0.110 |
Why?
|
Recovery of Function | 2 | 2015 | 2979 | 0.100 |
Why?
|
Young Adult | 9 | 2024 | 59243 | 0.100 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1999 | 1493 | 0.100 |
Why?
|
Joints | 1 | 2014 | 322 | 0.100 |
Why?
|
DNA | 3 | 2011 | 7212 | 0.100 |
Why?
|
ADAM Proteins | 1 | 2013 | 238 | 0.100 |
Why?
|
Patient Preference | 1 | 2019 | 924 | 0.100 |
Why?
|
Elasticity | 3 | 2009 | 655 | 0.100 |
Why?
|
Athletes | 1 | 2019 | 1137 | 0.100 |
Why?
|
Apoptosis | 3 | 2013 | 9486 | 0.100 |
Why?
|
Cold Temperature | 1 | 2015 | 785 | 0.090 |
Why?
|
Patient Satisfaction | 1 | 2024 | 3461 | 0.090 |
Why?
|
Regenerative Medicine | 1 | 2015 | 306 | 0.090 |
Why?
|
Leg Length Inequality | 1 | 2011 | 56 | 0.090 |
Why?
|
Treatment Failure | 1 | 2017 | 2645 | 0.090 |
Why?
|
Metabolism | 1 | 2012 | 193 | 0.090 |
Why?
|
Culture Media, Conditioned | 1 | 2012 | 522 | 0.090 |
Why?
|
Growth Differentiation Factor 6 | 1 | 2010 | 8 | 0.090 |
Why?
|
Procollagen | 1 | 2011 | 187 | 0.090 |
Why?
|
Diffusion Chambers, Culture | 1 | 2010 | 49 | 0.090 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2015 | 1651 | 0.090 |
Why?
|
Cell Differentiation | 4 | 2012 | 11528 | 0.090 |
Why?
|
Absorbable Implants | 1 | 2012 | 338 | 0.090 |
Why?
|
Epiphyses | 1 | 2011 | 190 | 0.090 |
Why?
|
Adult | 19 | 2024 | 221177 | 0.090 |
Why?
|
Equipment Failure | 1 | 2012 | 578 | 0.090 |
Why?
|
Immunoenzyme Techniques | 2 | 2006 | 1705 | 0.090 |
Why?
|
Suture Anchors | 1 | 2010 | 80 | 0.090 |
Why?
|
Hemorheology | 1 | 2010 | 144 | 0.080 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 2009 | 125 | 0.080 |
Why?
|
Growth Differentiation Factors | 1 | 2010 | 100 | 0.080 |
Why?
|
Prospective Studies | 7 | 2023 | 54425 | 0.080 |
Why?
|
Protein Denaturation | 1 | 2009 | 242 | 0.080 |
Why?
|
Periosteum | 1 | 2009 | 139 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1171 | 0.080 |
Why?
|
Cell Shape | 1 | 2010 | 371 | 0.080 |
Why?
|
Awards and Prizes | 1 | 2013 | 360 | 0.080 |
Why?
|
Ligaments, Articular | 1 | 2011 | 302 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2011 | 3492 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3358 | 0.080 |
Why?
|
Reoperation | 3 | 2023 | 4303 | 0.080 |
Why?
|
Platelet Count | 1 | 2011 | 781 | 0.080 |
Why?
|
Single-Blind Method | 1 | 2012 | 1572 | 0.070 |
Why?
|
Capillaries | 1 | 2011 | 755 | 0.070 |
Why?
|
Antigens, Differentiation | 1 | 2011 | 910 | 0.070 |
Why?
|
Range of Motion, Articular | 2 | 2011 | 1588 | 0.070 |
Why?
|
Rabbits | 2 | 2011 | 4772 | 0.070 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 1741 | 0.070 |
Why?
|
Muscle, Smooth | 2 | 2001 | 926 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3051 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5440 | 0.070 |
Why?
|
Injections | 1 | 2009 | 830 | 0.070 |
Why?
|
Body Temperature | 1 | 2009 | 781 | 0.070 |
Why?
|
Femoral Fractures | 1 | 2009 | 375 | 0.060 |
Why?
|
Bone Nails | 1 | 2007 | 220 | 0.060 |
Why?
|
Transplants | 1 | 2008 | 206 | 0.060 |
Why?
|
Parents | 1 | 2019 | 3563 | 0.060 |
Why?
|
In Situ Hybridization | 1 | 2009 | 1900 | 0.060 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2010 | 842 | 0.060 |
Why?
|
Epitopes | 1 | 2011 | 2503 | 0.060 |
Why?
|
Child | 8 | 2024 | 80153 | 0.060 |
Why?
|
Sports | 1 | 2011 | 705 | 0.060 |
Why?
|
Up-Regulation | 1 | 2013 | 4124 | 0.060 |
Why?
|
Lymphocytes | 1 | 2012 | 2612 | 0.060 |
Why?
|
Intraoperative Complications | 1 | 2011 | 1165 | 0.060 |
Why?
|
Bone Cysts | 1 | 2004 | 48 | 0.060 |
Why?
|
Arthroscopy | 1 | 2011 | 969 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39106 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2010 | 2358 | 0.060 |
Why?
|
Humeral Fractures | 1 | 2007 | 282 | 0.060 |
Why?
|
Gait | 2 | 2022 | 814 | 0.060 |
Why?
|
X-Ray Microtomography | 2 | 2016 | 456 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2015 | 3466 | 0.050 |
Why?
|
Risk Factors | 4 | 2022 | 74206 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2022 | 20098 | 0.050 |
Why?
|
Embryo, Mammalian | 1 | 2009 | 1675 | 0.050 |
Why?
|
United States | 3 | 2023 | 72334 | 0.050 |
Why?
|
Amino Acids | 1 | 2009 | 1718 | 0.050 |
Why?
|
Monocytes | 1 | 2012 | 2570 | 0.050 |
Why?
|
Foreign Bodies | 1 | 2006 | 402 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2012 | 3208 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2012 | 5869 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 318 | 0.050 |
Why?
|
Cell Line | 1 | 2015 | 15601 | 0.050 |
Why?
|
Sex Factors | 1 | 2015 | 10552 | 0.050 |
Why?
|
Biodegradation, Environmental | 1 | 2001 | 216 | 0.050 |
Why?
|
Chondroitin ABC Lyase | 1 | 2000 | 15 | 0.050 |
Why?
|
Lead | 1 | 2006 | 879 | 0.050 |
Why?
|
Cicatrix | 1 | 2007 | 798 | 0.050 |
Why?
|
Wounds, Gunshot | 1 | 2006 | 582 | 0.040 |
Why?
|
Ozone | 1 | 2024 | 483 | 0.040 |
Why?
|
Hyaluronic Acid | 1 | 2024 | 483 | 0.040 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2000 | 136 | 0.040 |
Why?
|
Normal Distribution | 1 | 2020 | 272 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2011 | 2882 | 0.040 |
Why?
|
Collagenases | 1 | 2000 | 222 | 0.040 |
Why?
|
Culture Techniques | 1 | 2000 | 531 | 0.040 |
Why?
|
Trypsin | 1 | 2000 | 495 | 0.040 |
Why?
|
Acetaminophen | 1 | 2024 | 554 | 0.040 |
Why?
|
Bone Density | 1 | 2012 | 3551 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2021 | 629 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3688 | 0.040 |
Why?
|
Green Fluorescent Proteins | 1 | 2004 | 2065 | 0.040 |
Why?
|
Middle Aged | 12 | 2019 | 220895 | 0.040 |
Why?
|
Stress, Mechanical | 3 | 2013 | 1674 | 0.040 |
Why?
|
Cartilage | 1 | 2022 | 806 | 0.040 |
Why?
|
Cell Death | 1 | 2004 | 1678 | 0.040 |
Why?
|
Cohort Studies | 4 | 2023 | 41487 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12059 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2022 | 22176 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2024 | 929 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10766 | 0.030 |
Why?
|
Aged | 8 | 2010 | 169289 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2004 | 2909 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 8002 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26125 | 0.030 |
Why?
|
Incidence | 1 | 2013 | 21353 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1880 | 0.030 |
Why?
|
Fractures, Bone | 1 | 2006 | 2046 | 0.030 |
Why?
|
Leadership | 1 | 2023 | 1385 | 0.030 |
Why?
|
Postoperative Period | 1 | 2019 | 1813 | 0.030 |
Why?
|
Protein Isoforms | 1 | 1999 | 1699 | 0.030 |
Why?
|
Bone Demineralization Technique | 1 | 2013 | 27 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 2273 | 0.030 |
Why?
|
Patient Compliance | 1 | 2024 | 2690 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2014 | 369 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2000 | 1349 | 0.030 |
Why?
|
Choice Behavior | 1 | 2019 | 824 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2024 | 80636 | 0.030 |
Why?
|
Blood Vessels | 1 | 1999 | 1113 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2020 | 2330 | 0.030 |
Why?
|
Logistic Models | 1 | 2006 | 13255 | 0.020 |
Why?
|
Osteonecrosis | 1 | 2013 | 229 | 0.020 |
Why?
|
Teriparatide | 1 | 2013 | 227 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2014 | 983 | 0.020 |
Why?
|
Hospitals | 1 | 2024 | 3882 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2020 | 2639 | 0.020 |
Why?
|
Pediatrics | 1 | 2024 | 3589 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2004 | 58976 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2001 | 2491 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 1188 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2013 | 1803 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15732 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1974 | 0.020 |
Why?
|
Bone Density Conservation Agents | 1 | 2013 | 795 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3249 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14666 | 0.020 |
Why?
|
Chelating Agents | 1 | 2006 | 387 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42230 | 0.020 |
Why?
|
Foot Injuries | 1 | 2006 | 149 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2011 | 3087 | 0.010 |
Why?
|
Spinal Fusion | 1 | 2013 | 1286 | 0.010 |
Why?
|
Blotting, Western | 2 | 2001 | 5035 | 0.010 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2003 | 71 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2013 | 3575 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6075 | 0.010 |
Why?
|
Infant | 1 | 2023 | 36192 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2010 | 3395 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6240 | 0.010 |
Why?
|
Ankle Injuries | 1 | 2004 | 339 | 0.010 |
Why?
|
Proteins | 1 | 2014 | 6032 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4063 | 0.010 |
Why?
|
Bone and Bones | 1 | 2008 | 2568 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 13367 | 0.010 |
Why?
|
Arthroplasty, Replacement | 1 | 2000 | 310 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2009 | 3357 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2000 | 1334 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 14031 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2003 | 6534 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2004 | 20570 | 0.000 |
Why?
|